HTRS Announces 2026 Mentored Research Award Recipients
MILWAUKEE, Wis. — The Hemostasis & Thrombosis Research Society Inc. (HTRS) is pleased to announce the recipients of its 2026 Mentored Research Awards (MRAs), a program designed to support early-career investigators pursuing clinical, translational, and basic science research in hemostasis and thrombosis.
MRAs provide critical funding and mentorship to fellows and junior faculty, helping to advance innovative research and foster the next generation of leaders in the field. Each award provides $165,000 over two years to support promising investigators as they build the foundation for future progression in hematology.
The 2026 recipients are:
Marisa Brake, PhD, is the recipient of the 2026 HTRS/Sanofi Mentored Research Award. Dr. Brake is Instructor of Medicine at Beth Israel Deaconess Medical Center and Harvard Medical School. Her project, funded by an educational grant from Sanofi, will investigate the genetic architecture of coagulation factor VII expression with the use of hormonal oral contraceptive use, with the goal of improving prediction of thrombotic risk in women.
Charlotte Story, MD, is the recipient of the 2026 HTRS/CSL Behring Mentored Research Award. Dr. Story is a Hematology Fellow at Johns Hopkins University School of Medicine. Her project will evaluate long-term renal and vascular outcomes in patients with complement-mediated thrombotic microangiopathy in the era of eculizumab using both retrospective and prospective approaches. Dr. Story’s work aims to define contemporary treatment patterns and inform endpoints for future studies in rare immuno-thrombotic syndromes.
Program Chairs of the HTRS Mentored Research Award, Drs. Brian Branchford (Versiti Blood Research Institute, Milwaukee, WI) and Christopher Ng (University of Colorado, Denver, CO) said, “The HTRSMentored Research Award plays a vital role in supporting the next generation of investigators in hemostasis and thrombosis. By providing early-career researchers with funding and resources, the program helps position them for long-term success within the field of classical hematology. With support from our industry partners, Sanofi and CSL Behring, we are proud to support these promising young scientists as they advance innovative research that will ultimately improve patient care.”
The MRA program is open to fellows and junior faculty with doctoral degrees (MD, PhD, DO, MBBS, or an equivalent medical or scientific doctoral degree) who are committed to advancing research in hemostasis and thrombosis under the guidance of experienced mentors. The award serves as an important steppingstone for investigators seeking to conduct independent research.